AstraZeneca has claimed UK approval for a new version of its respiratory triple therapy Trixeo Aerosphere that contains a propellant with a massively reduced global warming potential (GWP). The drug – ...
UK-based global pharma company AstraZeneca and US consumer products company Honeywell have announced a partnership to build a new "next generation" inhaler with a propellant that reduces Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback